Move seamlessly from research to GMP-compliant production.
Reprogrammed from CD34+ cord blood cells, ActiCells™ GMP-Matching RUO hiPSCs (Cat # ASE-9250) are an efficient, high-quality starting point for your cell-based therapy development. The reduced immunogenicity and lower somatic mutation load compared to adult cells give iPSCs reprogrammed from CD34+ cord blood cells a favorable therapeutic development profile, and the proven quality of iPSCs generated by Applied StemCell make ActiCells™ GMP-Matching RUO hiPSCs the reliable choice for your therapeutic development program.
As the isogenic RUO version of our ActiCells™ GMP hiPSCs, ActiCells™ RUO hiPSCs are an efficient and cost-effective way to optimize your cell-based therapy before moving into GMP manufacturing. Our team can also provide GMP-compliant iPSC gene editing, differentiation, cell banking, and manufacturing services to further streamline your path to the clinic.
Each vial of ActiCells™ GMP-Matching RUO hiPSCs contains 1 x 10^6 cells. Every lot is tested for viability following recovery from cryopreservation, functional pluripotency (formation of three germ layers), expression of pluripotency markers (Oct4, Sox2, Nanog, SSEA-4, and Tra-1-60), presence of alkaline phosphatase (AP), STR, sterility, and for the absence of mycoplasma and pathogens (CofA available upon request).
| Table Header | Table Header |
|---|---|
|
Reprogramming method |
Episomal |
|
Donor tissue |
CD34+ Umbilical Cord Blood Cells |
|
Gender |
Male |
|
Clinical information |
Normal |
|
Quantity |
1 x 106 cells/vial |
ActiCells™ GMP-Matching RUO hiPSCs maintain pluripotent stem cell morphology after thawing
Figure 1. ActiCells™ GMP-Matching RUO hiPSCs maintain pluripotent stem cell morphology 24 hours (left) and 72 hours (right) after thawing.
ActiCell GMP-Matching RUO hiPSCs are pluripotent
Figure 2. ActiCells™ GMP-Matching RUO hiPSCs show strong, uniform expression of pluripotency markers Oct4, Sox2, Nanog, SSEA-4, and TRA-1-60 (top row) with DAPI staining (blue) on the bottom row.
Figure 3. ActiCells™ GMP-Matching RUO hiPSCs differentiate into the three germ layers, demonstrating excellent differentiation potential. (A) Endoderm is demonstrated by alpha-fetoprotein (AFP) immunofluorescence (IF, green), (B) ectoderm by Neuron-specific class III β-tubulin (Tuj1) IF, and (C) mesoderm by smooth muscle actin (SMA) IF. DAPI staining in blue.
Didn’t find all the info you were looking for?
Still have questions?
No problem.
ActiCells™ GMP-Matching RUO hiPSCs are intended for research use only. They are isogenic with ActiCells™ GMP hiPSCs (ASE-9280) and are typically used for optimization before moving into the matching GMP line.
Each vial contains 1 x 106 cells, shipped on dry ice. Upon receipt, store in a liquid nitrogen freezer. For optimal results, use within six months of receipt.
Yes, a certificate of analysis (CofA) is available upon request, providing full details on viability, sterility, short tandem repeat profiling (STR), and mycoplasma testing.
We provide detailed protocols for thawing, feeder-free culturing, and cryopreservation, ensuring ease of use for your research team.
ASE-9250 iPSCs are derived from CD34+ umbilical cord blood cells using episomal reprogramming.
Episomal reprogramming is a non-integrative method, meaning it does not alter the genome, reducing the risk of genetic mutations.
Yes, ActiCells™ GMP-Matching RUO hiPSCs are validated for key pluripotency markers (Oct4, Sox2, Nanog, SSEA-4, TRA-1-60) and undergo rigorous quality control for genetic purity and viability.
Yes, ActiCells™ GMP-Matching RUO hiPSCs are an ideal starting point for gene-editing applications, including CRISPR/Cas9 modifications.
ActiCells™ GMP-Matching RUO hiPSCs can differentiate into all three germ layers (endoderm, mesoderm, ectoderm), making them suitable for diverse research applications.
